anmelden
25 € WM-Startbonus auf dein Cash-Konto
SMI Equal Weight
378,16
PKT
-2,78
PKT
-0,73
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Equal Weight-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.03.05 | Novartis Neutral | Sarasin Research | |
| 17.03.05 | UBS Buy | Helvea | |
| 18.03.05 | ABB (Asea Brown Boveri) Overweight | Lehman Brothers | |
| 18.03.05 | Geberit Reduce | Helvea | |
| 16.03.05 | Kühne + Nagel International Neutral | Sarasin Research | |
| 17.03.05 | Roche Buy | Helvea | |
| 16.03.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 17.03.05 | Novartis Outperform | Goldman Sachs | |
| 17.03.05 | Roche In-Line | Goldman Sachs | |
| 16.03.05 | Swiss Life Sell | Merck Finck & Co | |
| 15.03.05 | UBS Overweight | JP Morgan | |
| 15.03.05 | Kühne + Nagel International Market Perform | Vontobel | |
| 15.03.05 | UBS Overweight | JP Morgan | |
| 15.03.05 | Logitech Neutral | Sarasin Research | |
| 14.03.05 | Swiss Life Marketperformer | LB Rheinland-Pfalz | |
| 14.03.05 | Kühne + Nagel International Neutral | Sarasin Research | |
| 14.03.05 | Swiss Life Buy | M.M. Warburg | |
| 16.03.05 | Kühne + Nagel International Neutral | Helvea | |
| 14.03.05 | Swiss Life Outperform | HypoVereinsbank | |
| 15.03.05 | Swiss Life Akkumulieren | Nord LB | |
| 11.03.05 | Swisscom Neutral | Sarasin Research | |
| 11.03.05 | Novartis Neutral | Sarasin Research | |
| 17.03.05 | UBS Outperform | Credit Suisse First Boston | |
| 14.03.05 | Swisscom Underweight | Lehman Brothers | |
| 11.03.05 | Novartis Buy | Helvea | |
| 11.03.05 | Geberit Buy | Sarasin Research | |
| 10.03.05 | Logitech Accumulate | Helvea | |
| 10.03.05 | Kühne + Nagel International Neutral | Sarasin Research | |
| 10.03.05 | Swisscom Neutral | Helvea | |
| 10.03.05 | Novartis Neutral | Sarasin Research | |
| 10.03.05 | Swisscom Neutral | Sarasin Research | |
| 10.03.05 | Roche Buy | Sarasin Research | |
| 09.03.05 | Novartis Buy | Merrill Lynch | |
| 10.03.05 | Sika Neutral | Sarasin Research | |
| 08.03.05 | Logitech Market Outperform | Avondale Partners | |
| 09.03.05 | Holcim Market Outperform | Vontobel | |
| 09.03.05 | Swisscom Neutral | Sarasin Research | |
| 09.03.05 | Sika Neutral | Helvea | |
| 08.03.05 | Holcim Neutral | Sarasin Research | |
| 08.03.05 | UBS Overweight | Morgan Stanley |